These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 17635508)

  • 21. Treatment of acne vulgaris with 2% topical tea lotion.
    Sharquie KE; Al-Turfi IA; Al-Shimary WM
    Saudi Med J; 2006 Jan; 27(1):83-5. PubMed ID: 16432600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clindamycin lotion alone versus combination lotion of clindamycin phosphate plus tretinoin versus combination lotion of clindamycin phosphate plus salicylic acid in the topical treatment of mild to moderate acne vulgaris: a randomized control trial.
    NilFroushzadeh MA; Siadat AH; Baradaran EH; Moradi S
    Indian J Dermatol Venereol Leprol; 2009; 75(3):279-82. PubMed ID: 19439881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study.
    Lee JW; Yoo KH; Park KY; Han TY; Li K; Seo SJ; Hong CK
    Br J Dermatol; 2011 Jun; 164(6):1369-75. PubMed ID: 21114478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photodynamic therapy for acne vulgaris: a randomized, controlled, split-face clinical trial of topical aminolevulinic acid and pulsed dye laser therapy.
    Orringer JS; Sachs DL; Bailey E; Kang S; Hamilton T; Voorhees JJ
    J Cosmet Dermatol; 2010 Mar; 9(1):28-34. PubMed ID: 20367670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Tretinoin 0.05% Lotion for the Once-daily Treatment of Moderate-to-Severe Acne Vulgaris in an Adult and Adolescent Female Population.
    Kircik LH; Baldwin H; Lain E; Guenin E; Harris S; Bhatt V
    J Drugs Dermatol; 2019 Feb; 18(2):178-188. PubMed ID: 30811141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 Trials.
    Tanghetti EA; Werschler WP; Lain T; Guenin E; Martin G; Pillai R
    J Drugs Dermatol; 2020 Jan; 19(1):70-77. PubMed ID: 31985914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne.
    Skidmore R; Kovach R; Walker C; Thomas J; Bradshaw M; Leyden J; Powala C; Ashley R
    Arch Dermatol; 2003 Apr; 139(4):459-64. PubMed ID: 12707093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized double-blind study to assess the effects of silicic acid compared to placebo in patients with mild to moderate acne.
    Fernandez C; Adamson K; Dale M; Cunliffe WJ
    J Dermatolog Treat; 2005; 16(5-6):287-94. PubMed ID: 16428147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tazarotene 0.045% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in Adult Males.
    Cook-Bolden FE; Gold MH; Guenin E
    J Drugs Dermatol; 2020 Jan; 19(1):78-85. PubMed ID: 32023013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action.
    Pollock B; Turner D; Stringer MR; Bojar RA; Goulden V; Stables GI; Cunliffe WJ
    Br J Dermatol; 2004 Sep; 151(3):616-22. PubMed ID: 15377348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Tolerability of a Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate or Severe Acne Vulgaris in Adult Females.
    Harper JC; Baldwin H; Stein Gold L; Guenin E
    J Drugs Dermatol; 2019 Nov; 18(11):1147-1154. PubMed ID: 31741360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of irritative potential of nadifloxacin 1% when combined with other topical anti-acne agents.
    Wilhelm KP; Wilhelm D; Neumeister C; Zsolt I; Schwantes U
    Clin Exp Dermatol; 2012 Mar; 37(2):112-7. PubMed ID: 22103435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris.
    Draelos ZD; Carter E; Maloney JM; Elewski B; Poulin Y; Lynde C; Garrett S;
    J Am Acad Dermatol; 2007 Mar; 56(3):439.e1-10. PubMed ID: 17208334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris.
    Shalita AR; Myers JA; Krochmal L; Yaroshinsky A;
    J Drugs Dermatol; 2005; 4(1):48-56. PubMed ID: 15696985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Tretinoin 0.05% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in a Hispanic Population.
    Cook-Bolden FE; Weinkle SH; Guenin E; Bhatt V
    J Drugs Dermatol; 2019 Jan; 18(1):32-38. PubMed ID: 30681791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical therapy of acne vulgaris using 2% tea lotion in comparison with 5% zinc sulphate solution.
    Sharquie KE; Noaimi AA; Al-Salih MM
    Saudi Med J; 2008 Dec; 29(12):1757-61. PubMed ID: 19082228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in an Asian Population.
    Han G; Armstrong AW; Desai SR; Guenin E
    J Drugs Dermatol; 2019 Sep; 18(9):910-916. PubMed ID: 31524347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle-Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris.
    Tanghetti EA; Kircik LH; Green LJ; Guenin E; Harris S; Martin G; Pillai R
    J Drugs Dermatol; 2019 Jun; 18(6):542. PubMed ID: 31251546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of clindamycin phosphate 1 percent topical lotion and placebo in the treatment of acne vulgaris.
    Kuhlman DS; Callen JP
    Cutis; 1986 Sep; 38(3):203-6. PubMed ID: 2945704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Impact of Gender and Race on Efficacy and Safety.
    Lain E; Day D; Harper J; Guenin E
    J Drugs Dermatol; 2019 Nov; 18(11):1128-1138. PubMed ID: 31741356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.